Plasma levels of Clusterin are representative of the early phase of the neurodegenerative process in Parkinson’s disease

MLA

Artor Niccoli Asabella, et al. “Plasma Levels of Clusterin Are Representative of the Early Phase of the Neurodegenerative Process in Parkinson’s Disease.” Journal of Clinical and Molecular Medicine, vol. 1, Jan. 2018. EBSCOhost, https://doi.org/10.15761/jcmm.1000102.

APA

Artor Niccoli Asabella, Lorenzo Polimeno, R. Buquicchio, Valentina Lavelli, Giovanni De Fazio, Giuseppe Rubini, Antonio Mazzocca, & Riccardo Polimeno. (2018). Plasma levels of Clusterin are representative of the early phase of the neurodegenerative process in Parkinson’s disease. Journal of Clinical and Molecular Medicine, 1. https://doi.org/10.15761/jcmm.1000102

Chicago

Artor Niccoli Asabella, Lorenzo Polimeno, R. Buquicchio, Valentina Lavelli, Giovanni De Fazio, Giuseppe Rubini, Antonio Mazzocca, and Riccardo Polimeno. 2018. “Plasma Levels of Clusterin Are Representative of the Early Phase of the Neurodegenerative Process in Parkinson’s Disease.” Journal of Clinical and Molecular Medicine 1 (January). doi:10.15761/jcmm.1000102.